Commentary Open Access
Flavor alterations in cancer treatment: a biomedical gastronomic approach to its complex nature
Graham Ellender1,*
- `1Adjunct Senior Lecturer, Adelaide University, AHMS Building, North Terrace, Adelaide, Australia 5000
Corresponding Author
Graham Ellender, graham.ellender@adelaide.edu.au
Received Date: March 20, 2026
Accepted Date: April 17, 2026
In an earlier publication, gastronomy is proffered, although rarely considered, as having a place in clinical practice of medicine and surgery with an indirect role in conferring interventions to compensate for the adverse effects of smell and taste alterations in cancer chemotherapy on nutrient intake [1].
Copyright: © 2026 Ellender G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Ocular surface squamous neoplasia treated with topical chemotherapy
A man in his 90s presented to clinic with a conjunctival lesion on the right eye noticed two months prior. The patient denied pain but endorsed worsening blurry vision. The patient’s past medical history was significant for skin cancer on the right ear removed 3 years ago, and a history of ocular surface lesion removal on one eye approximately 20 years ago that was negative for any neoplasia. Slit lamp photograph revealed a gelatinous and opalescent lesion suspicious for ocular surface squamous neoplasia (OSSN) and the high-resolution optical coherence tomography (HROCT) cut (arrow)
Further comments on the single-cell protein ingredient manufactured from a non-GMO Corynebacterium glutamicum as an alternative protein nutrition
In the previous study, Park et al. reported the efficacy of a single-cell protein manufactured from a growth-accelerated high-vital Corynebacterium glutamicum strain and potential strain selection strategy for development of non-GMO industrial strains harboring enriched target nutritional component, named as growth?acceleration?targeted evolution (G.A.T.E.) strategy [1].
Efbemalenograstim alfa, a long-acting granulocyte colony-stimulating factor, a novel dimeric G-CSF Fc fusion protein for reducing the risk of febrile neutropenia following chemotherapy
Chemotherapy?induced neutropenia (CIN) can cause life-threatening complications such as febrile neutropenia (FN) or other infections. Patients who develop FN often require prolonged hospitalizations and treatment with broad-spectrum antibiotics.
Pre-school hilly and forest-dense ethnic children nutrition
Child under nutrition is a serious issue and burning public health problem worldwide. Pre-school children usually require special care. It is evident that pre-school children suffer highest prevalence of mortality and sufferings of disease. If malnutrition starts in early stages of life it is difficult to recover. According to World Health Organization under nutrition of children requires immediate attention.
Chemotherapy, immunotherapy, and antiangiogenesis: Emerging trends in the comprehensive treatment of advanced gastric cancer
Gastric or gastroesophageal junction (GEJ) adenocarcinoma remains a fatal condition worldwide, ranking fifth in prevalence and fourth in mortality globally [1]. The treatment of advanced gastric cancer is currently stratified based on MSI (Microsatellite Instability) status and HER2 status.